Antioxidant treatment with edaravone or taurine ameliorates diabetes-induced testicular dysfunction in the rat
Authors:
- 5 July 2012
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 369 (1-2) , 195-204
Abstract
Diabetes mellitus with the subsequent generation of reactive oxygen species represents a major risk factor for testicular dysfunction (TD). We investigate whether administration of antioxidants edaravone and taurine could prevent type 1 diabetes-induced TD in the rat. Six-week-old male Wistar rats were divided into four groups. Group A was treated with citrate–phosphate buffer plus normal saline, whereas in the other three groups, diabetes was induced by streptozotocin (50 mg/kg intraperitoneally). Subsequently, the diabetic rats were treated for 4 weeks either with normal saline (group B), edaravone (10 mg/Kg/day, intraperitoneally; group C), or taurine (500 mg/Kg/day, intraperitoneally; group D). Body, testicular, and epididymal weight, serum glucose, malondialdehyde levels, 8-Hydroxy-2’-deoxyguanosine(8-OH-dG) levels, testicular catalase activity, and serum testosterone levels were determined. Histological examination and the Johnsen score were used to observe and evaluate, respectively, the morphological changes in the testes. TUNEL assay was used to examine DNA fragmentation. Mating studies were performed in order to evaluate the fertility potential of male rats in each group. Edaravone or taurine treatment prevented significantly the decreased body, testicular, and epididymal weight induced by diabetes. Moreover, edaravone or taurine significantly decreased the diabetes-induced malondialdehyde levels, 8-OHdG levels, the morphological damage, and the number of apoptotic cells. Taurine, but not edaravone, increased significantly the testicular catalase activity. The antioxidant treatment had no effect on the fertility potential of the diabetic rats. The morphological damage, increased lipid peroxidation, and apoptosis in testicular tissue can be significantly relieved by edaravone or taurine treatment through suppressing the increased oxidative stress in the rat testis.Keywords
This publication has 40 references indexed in Scilit:
- Exacerbation of diabetes-induced testicular apoptosis by zinc deficiency is most likely associated with oxidative stress, p38 MAPK activation, and p53 activation in miceToxicology Letters, 2011
- Effect of Experimental Diabetes and STZ on Male Fertility Capacity. Study in RatsJournal of Andrology, 2010
- Repetitive exposures to low-dose X-rays attenuate testicular apoptotic cell death in streptozotocin-induced diabetes ratsToxicology Letters, 2010
- Streptozotocin-induced diabetes increases the interaction of Bad/Bcl-XL and decreases the binding of pBad/14–3–3 in rat testisLife Sciences, 2007
- Occurrence of oxidative impairments, response of antioxidant defences and associated biochemical perturbations in male reproductive milieu in the Streptozotocin‐diabetic ratInternational Journal of Andrology, 2007
- Early oxidative stress in testis and epididymal sperm in streptozotocin-induced diabetic mice: Its progression and genotoxic consequencesReproductive Toxicology, 2007
- Hormonal and genetic control of germ cell apoptosis in the testisReviews of Reproduction, 1999
- Relationship between iron-catalysed lipid peroxidation potential and human sperm functionReproduction, 1993
- Ultrastructural changes in Leydig cells of streptozotocininduced diabetic ratsThe Anatomical Record, 1979
- Leydig cell function in streptozotocin-induced diabetic ratsCellular and Molecular Life Sciences, 1979